You searched for "registrars"
Medical statistics for urologists: part 1
Part 2 of this article is available here, and Part 3 here Clinicians often consider statistics to be a dry and challenging subject. However, an understanding of the basics of statistic methods underpins the interpretation and use of current best...New study shows UK may finally be ready for prostate cancer screening
Prostate Cancer UK study shows tens of thousands fewer men each year face unnecessary harm thanks to new screening techniques. New research by Prostate Cancer UK shows that the UK may finally be in a position to roll out a...Introduction to prostate cryotherapy
Introduction Cryotherapy was first described by Dr James Arnott in 1850 where he used crushed ice and salt to get temperatures as low as -24oC, in the treatment of cervical and breast tumours [1]. The literature on prostatic cryotherapy dates...45th Congress of the Société Internationale d’Urologie (SIU)
IN PERSON registration fees include: Scientific Sessions (in person and virtual) Complimentary access to the 7th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting (Friday, October 31) Access to the Exhibit Hall Complimentary access to scientific content on the virtual congress platform, SIU@U, including live chats, virtual exhibit, gamification and session polling Access to the Congress Mobile App VIRTUAL registration fees include: Key Scientific Sessions broadcast live and available on-demand, including the Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting Full access to the virtual congress platform, SIU@U, including live chat, virtual exhibit, gamification and session polling Access to the Congress Mobile AppBladder cancer diagnosis and follow up: A new proven urinary biomarker to support the post COVID-19 recovery phase
Since lockdown began most urologists have been following the advice of BAUS Oncology, to minimise the risk of exposure of patients and staff to potential COVID-19 infection: the result is an increasing backlog of patients requiring tests to determine if...Focal therapy for prostate cancer – ready for prime time?
The current therapeutic ratio for radical therapy in many men with localised prostate cancer is not ideal. For a significant side-effect profile, there seems to be a small survival benefit over a 10-15 year period. A strategy that might balance...
Is AS in SRM more convincing than in prostate cancer?
This article reviews active surveillance (AS) in the management of small renal masses (SRM), the role of renal tumour biopsy (RTB), patient selection, tumour growth kinetics, and outcomes. SRMs which are defined as masses ≤4 cm in diameter and enhance...
